FrancophonIA/ELRC3.0 huggingface dataset:
English: If overdose with SIMBRINZA occurs treatment should be symptomatic and supportive.
Slovenian: Če pride do prevelikega odmerjanja zdravila SIMBRINZA, naj bo zdravljenje simptomatsko in podporno.
English: If you stop using SIMBRINZA the pressure in your eye will not be controlled, which could lead to loss of sight.
Slovenian: Če prenehate uporabljati zdravilo SIMBRINZA, vaš očesni tlak ne bo nadzorovan in lahko pride do izgube vida.
English: Tell your doctor, optometrist (optician) or pharmacist if you are using, have recently used, or might use any other medicines.
Slovenian: Obvestite zdravnika, optometrista (optika) ali farmacevta, če uporabljate, ste pred kratkim uporabljali ali pa boste morda začeli uporabljati katero koli drugo zdravilo.
English: The use of brimonidine has been associated with minimal decreases in blood pressure.
Slovenian: Uporaba brimonidina je bila povezana z minimalnim znižanjem krvnega tlaka.
English: However, the combination product is not recommended for patients with severe renal impairment (creatinine clearance <30 mL/minute).
Slovenian: Kljub temu pa kombinirano zdravilo ni priporočljivo za uporabo pri bolnikih s hudo ledvično okvaro (očistek kreatinina < 30 ml/minuto).
English: 1, corneal deposits (keratic precipitates)
Slovenian: 1,roženični depoziti (keratinski precipitati)
English: Both substances work together to reduce pressure within the eye.
Slovenian: Obe učinkovini skupaj znižujeta očesni tlak.
English: What SIMBRINZA is and what it is used for
Slovenian: Kaj je zdravilo SIMBRINZA in za kaj ga uporabljamo
English: If blurred vision occurs at instillation the patient must wait until the vision clears before driving or using machines.
Slovenian: Če ima po vkapanju bolnik zamegljen vid, mora počakati, da se mu vid zbistri, preden sme voziti ali upravljati stroje.
English: Treatment of children 2 years and above (especially those in the 2-7 age range and/or weighing <20 kg) is not recommended because of the potential for central nervous system-related side effects (see section 4.9).
Slovenian: Zdravljenje otrok, starih 2 leti ali več (posebno tistih, ki so stari od 2 do 7 let in imajo telesno maso < 20 kg), ni priporočljivo zaradi nevarnosti neželenih učinkov na centralni živčni sistem (glejte poglavje 4.9).
English: This may result in a decrease in systemic side effects and an increase in local activity (see section 4.4).
Slovenian: Tako lahko doseže zmanjšanje sistemskih neželenih učinkov in povečanje lokalne aktivnosti zdravila (glejte poglavje 4.4).
English: It was reported that the hypotensive episode was followed by rebound hypertension.
Slovenian: Poročali so, da je hipotenzivni epizodi pozneje sledila povratna hipertenzija.
English: 2, angina pectoris
Slovenian: 2, angina pektoris
English: 2, alopecia
Slovenian: 2, alopecija
English: If you are using other eye drops as well as SIMBRINZA, wait at least five minutes between using SIMBRINZA and the other drops.
Slovenian: Če uporabljate tudi druge kapljice za oko poleg zdravila SIMBRINZA, počakajte najmanj pet minut med uporabo zdravila SIMBRINZA in drugih kapljic.
English: In rats and monkeys, urinary metabolites accounted for 60 to 75% of oral or intravenous doses.
Slovenian: Pri podganah in opicah so presnovki v seču obsegali od 60 % do 75 % peroralnega ali intravenskega odmerka.
English: The patient's airway should be maintained.
Slovenian: Pri bolniku je treba ohranjati proste dihalne poti.
English: Neonates and infants under the age of 2 years (see section 4.4).
Slovenian: Novorojenčki in dojenčki, mlajši od 2 let (glejte poglavje 4.4).
English: The potential effects following cessation of treatment with SIMBRINZA have not been studied.
Slovenian: Morebitnih učinkov po prenehanju zdravljenja z zdravilom SIMBRINZA niso proučevali.
English: Given the low systemic exposure to brimonidine following topical ocular administration, it is expected that changes in plasma exposure would not be clinically relevant.
Slovenian: Glede na majhno stopnjo sistemske izpostavljenosti brimonidinu po njegovi topikalni očesni uporabi lahko pričakujemo, da spremembe plazemske izpostavljenosti zdravilu ne bodo klinično pomembne.
English: Animal studies with oral brimonidine do not indicate direct harmful effects with respect to reproductive toxicity.
Slovenian: Študije na živalih z uporabo peroralnega brimonidina ne kažejo neposrednih škodljivih učinkov na sposobnost razmnoževanja.
English: 2, amnesia
Slovenian: 2, amnezija
English: If signs of serious reactions or hypersensitivity occur, the use of this medicinal product should be discontinued.
Slovenian: Če se pojavijo znaki resnih reakcij ali preobčutljivosti na zdravilo, prenehajte z uporabo tega zdravila.
English: Use in adults, including the elderly The recommended dose is one drop of SIMBRINZA in the affected eye(s) two times daily.
Slovenian: Uporaba pri odraslih, vključno s starostniki Priporočeni odmerek je ena kapljica zdravila SIMBRINZA v prizadeto oko (oči) dvakrat na dan.
English: Patients should be instructed to keep the bottle tightly closed when not in use.
Slovenian: Bolnike poučite, da mora biti kapalni vsebnik tesno zaprt, ko ni v uporabi.
English: In contrast, brimonidine exhibits linear pharmacokinetics over the clinically therapeutic dose range.
Slovenian: Nasprotno pa ima brimonidin linearno farmakokinetiko v razponu kliničnih terapevtskih odmerkov.
English: 2, medication residue Not known: chest pain
Slovenian: 2, ostanki zdravila Neznana: bolečine v prsnem košu
English: Temporary blurred vision or other visual disturbances may affect the ability to drive or use machines.
Slovenian: Začasno zamegljen vid ali druge motnje vida lahko vplivajo na sposobnost vožnje ali upravljanja strojev.
English: Adults who accidentally swallowed medicines containing brimonidine experienced a decreased heart rate, decreased blood pressure which may be followed by increased blood pressure, heart failure, difficulty breathing and effects in the nervous system.
Slovenian: Pri odraslih, ki so nenamerno zaužili zdravila z brimonidinom, so se pojavili zmanjšan srčni utrip, znižan krvni tlak, ki mu je lahko sledil zvišan krvni tlak, srčno popuščanje, težave z dihanjem in učinki na živčni sistem.
English: Whole blood elimination half-life is prolonged (>100 days) in humans due to RBC carbonic anhydrase binding.
Slovenian: Razpolovni čas izločanja iz polne krvi pri človeku je podaljšana (>100 dni) zaradi vezave na karboanhidrazo v eritrocitih.
English: Brimonidine tartrate may cause ocular allergic reactions.
Slovenian: Brimonidinijev tartrat lahko povzroči očesne alergijske reakcije.
English: Specifically, patients wearing contact lenses have not been studied and careful monitoring of these patients when using brinzolamide is recommended, since carbonic anhydrase inhibitors may affect corneal hydration and wearing contact lenses might increase the risk for the cornea (for further instructions on wearing contact lenses, see below under “Benzalkonium chloride”).
Slovenian: Natančneje, v raziskavah niso obravnavali bolnikov, ki nosijo kontaktne leče, zato priporočamo skrbno spremljanje teh bolnikov med uporabo brinzolamida, saj lahko zaviralci karboanhidraze vplivajo na hidracijo roženice in bi pri njih nošenje kontaktnih leč lahko povečalo tveganje za okvaro roženice (za nadaljnja navodila o nošenju kontaktnih leč glejte spodaj pod 'Benzalkonijev klorid').
English: The European Medicines Agency has waived the obligation to submit the results of studies with SIMBRINZA in all subsets of the paediatric population in the treatment of glaucoma and ocular hypertension (see section 4.2 for information on paediatric use).
Slovenian: Evropska agencija za zdravila je odstopila od zahteve za predložitev rezultatov študij z zdravilom SIMBRINZA za vse podskupine pediatrične populacije v zdravljenju glavkoma in očesne hipertenzije (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
English: The effects of renal and hepatic impairment on the systemic pharmacokinetics of brimonidine have not been evaluated.
Slovenian: Vpliva ledvične in jetrne okvare na sistemsko farmakokinetiko brimonidina niso ovrednotili.
English: Serum electrolyte levels (particularly potassium) and blood pH levels must be monitored.
Slovenian: Spremljati morate serumske koncentracije elektrolitov (še posebej kalija) in pH vrednost krvi.
English: Available pharmacodynamic/toxicological data in animals have shown that following oral administration, minimal levels of brinzolamide are excreted in breast milk.
Slovenian: Farmakodinamski in toksikološki podatki pri živalih, ki so na voljo, so pokazali, da se po peroralni uporabi v materino mleko izločajo minimalne količine brinzolamida.
English: Brinzolamide and Ndesethylbrinzolamide do not inhibit cytochrome P450 isozymes at concentrations at least 100-fold above maximum systemic levels.
Slovenian: Brinzolamid in Ndesetilbrinzolamid ne zavirata izoencimov citokroma P450 pri koncentracijah, ki predstavljajo najmanj 100-kratnik največjih sistemskih vrednosti.
English: Very rare: uveitis
Slovenian: Zelo redki: uveitis
English: It is likely to be caused by passage of the eye drops in the nasopharynx via the nasolacrimal canal and is mainly attributable to the brinzolamide component of SIMBRINZA.
Slovenian: Verjetno ga povzroča prehajanje kapljic za oko v nazofarinks skozi nazolakrimalni kanal, pripisujejo pa ga predvsem brinzolamidu v zdravilu SIMBRINZA.
English: Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1.
Slovenian: Preobčutljivost na učinkovini ali katero koli pomožno snov, navedeno v poglavju 6.1.
English: Steady-state exposure does not increase in a doseproportional manner.
Slovenian: Izpostavljenost zdravilu v stanju dinamičnega ravnovesja ne narašča sorazmerno odmerku.
English: • Severe skin reactions, including rash or redness or itching on your body or eyes
Slovenian: • hude kožne reakcije, vključno z izpuščajem, rdečino ali srbenjem po telesu ali v očeh,
English: If you are breast-feeding, SIMBRINZA may pass into your milk.
Slovenian: Če dojite, lahko zdravilo SIMBRINZA prehaja v vaše mleko.
English: Brinzolamide is primarily eliminated in urine unchanged.
Slovenian: Brinzolamid se izloča predvsem z urinom, v nespremenjeni obliki.
English: While the duration of IOP-lowering effect for SIMBRINZA has not been studied, the IOP-lowering effect of brinzolamide is expected to last for 5-7 days.
Slovenian: Čeprav pri uporabi zdravila SIMBRINZA niso proučevali trajanja učinka na znižanje očesnega tlaka, je pričakovati, da ta učinek pri brinzolamidu traja od 5 do 7 dni.
English: Tiny amounts of hydrochloric acid and/or sodium hydroxide are added to keep acidity levels (pH levels) normal.
Slovenian: Zelo majhne količine klorovodikove kisline in/ali natrijevega hidroksida so dodane za ohranjanje normalne kislosti (pH vrednosti).
English: Do not use SIMBRINZA unless clearly indicated by your doctor.
Slovenian: Zdravila SIMBRINZA ne smete uporabljati, razen če vam ga vaš zdravnik izrecno predpiše.
English: Missed dose If a dose is missed, treatment should be continued with the next dose as planned.
Slovenian: Izpuščeni odmerek Če bolnik izpusti posamezen odmerek, naj nadaljuje zdravljenje z naslednjim načrtovanim odmerkom.
English: Within each frequency-grouping, adverse reactions are presented in order of decreasing seriousness.
Slovenian: V razvrstitvah pogostnosti so neželeni učinki navedeni po padajoči resnosti.
English: Uncommon: vertigo
Slovenian: Občasni: vertigo
English: These findings were associated with metabolic acidosis with decreased body weight gain in dams and decreased foetal weights.
Slovenian: Ti izsledki so bili povezani z metabolično acidozo in z zmanjšanim pridobivanjem telesne mase pri samicah ter zmanjšano telesno maso plodov.
English: Effects in non-clinical reproduction and development toxicity studies were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use.
Slovenian: V predkliničnih študijah vpliva na sposobnost razmnoževanja in razvoj so opazili učinke samo pri izpostavljenostih, ki so bile toliko večje od največje izpostavljenosti pri človeku, da so jih lahko šteli za nepomembne za klinično uporabo.
English: • General side effects: fainting, increased blood pressure
Slovenian: • Splošni neželeni učinki: omedlevica, zvišan krvni tlak.
English: Manufacturer Alcon Cusí, S.A. Camil Fabra 58 08320 El Masnou Spain
Slovenian: Izdelovalec Alcon Cusí, S.A. Camil Fabra 58 08320 El Masnou Španija
English: Oxidative cleavage of the imidazoline ring to 5-bromo-6-guanidinoquinoxaline is also observed.
Slovenian: Opazili so tudi oksidativni razcep imidazolinskega obroča na 5-bromo-6-gvanidinokinoksalin.
English: Data in rats showed some biliary excretion (about 30%), primarily as metabolites.
Slovenian: Podatki pri podganah so pokazali tudi nekaj izločanja z žolčem (približno 30 %), predvsem v obliki presnovkov.
English: The possible effect of brinzolamide on corneal endothelial function has not been investigated in patients with compromised corneas (particularly in patients with low endothelial cell count).
Slovenian: Morebitnega učinka brinzolamida na delovanje roženičnega endotelija še niso raziskovali pri bolnikih z okvaro roženice (posebno pri tistih z majhnim številom endotelijskih celic).
English: SIMBRINZA is not recommended during pregnancy and in women of childbearing potential not using contraception.
Slovenian: Uporaba zdravila SIMBRINZA ni priporočljiva v času nosečnosti in pri ženskah v rodni dobi, ki ne uporabljajo kontracepcije.
English: In rats doses of 18 mg/kg/day (783 times the recommended daily clinical dose), but not 6 mg/kg/day, resulted in slightly reduced ossification of skull and sternebrae of foetuses.
Slovenian: Pri podganah so odmerki 18 mg/kg/dan (783-kratnik priporočenega kliničnega dnevnega odmerka), ne pa 6 mg/kg/dan, povzročili nekoliko zmanjšano osifikacijo lobanje in sternalnih reber plodov.
English: 2, bradycardia
Slovenian: 2, bradikardija
English: 2, bronchial hyperactivity 2, pharyngolaryngeal pain
Slovenian: 2, hiperaktivnost bronhijev 2, faringolaringealna bolečina
English: Hold the bottle, pointing down, between your thumb and fingers.
Slovenian: Kapalni vsebnik držite med palcem in prsti, obrnjeno navzdol.
English: Do not squeeze the bottle: it is designed so that a gentle press on the bottom is all that it needs (picture 2).
Slovenian: Ne stiskajte kapalnega vsebnika - izdelan je tako, da zadostuje že rahel pritisk na njegovo dno (slika 2).
English: Hepatic and/or renal impairment
Slovenian: Jetrna in/ali ledvična okvara
English: Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or a disorder of the cornea (the clear layer at the front of the eye).
Slovenian: Benzalkonijev klorid lahko povzroči tudi draženje oči, še posebno če imate suhe oči ali težave z roženico (prosojni, sprednji del očesa).
English: • Effects in the eye: decreased growth of eyelashes
Slovenian: • Učinki na oko: zmanjšana rast trepalnic.
English: The medicinal product should not be injected.
Slovenian: Tega zdravila ne smete injicirati.
English: Dose related decreases in foetal weights were observed in pups of dams given 2 to 18 mg/kg/day.
Slovenian: Od odmerka odvisno zmanjšanje telesne mase plodov so opažali pri mladičih samic, ki so prejemale od 2 do 18 mg/kg/dan.
English: Adverse reactions commonly associated with the brimonidine component of SIMBRINZA include the development of ocular allergic type reactions, fatigue and/or drowsiness, and dry mouth.
Slovenian: Med neželene učinke, ki so običajno povezani z brimonidinom v zdravilu SIMBRINZA, sodijo tudi nastanek očesnih alergijskih reakcij, utrujenost in/ali dremavost ter suha usta.
English: Tell your doctor if you are taking or intend to take any of the following medicines: - medicines to lower blood pressure - heart medicines including digoxin (used to treat heart conditions) - other medicines for glaucoma that also treat altitude sickness known as acetazolamide,
Slovenian: Obvestite svojega zdravnika, če uporabljate ali boste uporabljali katero koli od naslednjih zdravil: - zdravila za zniževanje krvnega tlaka, - zdravila za srce, vključno z digoksinom (uporablja se za zdravljenje bolezni srca), - druga zdravila za zdravljenje glavkoma, ki se uporabljajo tudi za zdravljenje višinske bolezni,
English: The systemic pharmacokinetics of brinzolamide and brimonidine, alone or in combination, in paediatric patients have not been studied.
Slovenian: Sistemske farmakokinetike brinzolamida in brimonidina pri njuni samostojni uporabi ali v kombinaciji pri pediatričnih bolnikih niso proučevali.
English: How to store SIMBRINZA Contents of the pack and other information
Slovenian: Shranjevanje zdravila SIMBRINZA Vsebina pakiranja in dodatne informacije
English: Brimonidine is extensively metabolised by hepatic aldehyde oxidase, with formation of 2oxobrimonidine, 3-oxobrimonidine and 2,3-dioxobrimonidine being the major metabolites.
Slovenian: Brimonidin se obsežno presnovi z jetrno aldehidno oksidazo s tvorbo 2-oksobrimonidina, 3oksobrimonidina in 2,3-dioksobrimonidina kot glavnih presnovkov.
English: Patients must be instructed to remove contact lens prior to application of SIMBRINZA and wait at least 15 minutes before reinsertion.
Slovenian: Bolnikom svetujte, naj kontaktne leče odstranijo pred vkapanjem zdravila SIMBRINZA in naj po vkapanju počakajo najmanj 15 minut, preden si jih spet vstavijo.
English: Hypersensitivity to sulphonamides (see section 4.4).
Slovenian: Preobčutljivost na sulfonamide (glejte poglavje 4.4).
English: Tricyclic antidepressants may blunt the ocular hypotensive response of SIMBRINZA.
Slovenian: Triciklični antidepresivi lahko zmanjšajo hipotenzivni odziv očesa na zdravilo SIMBRINZA.
English: 2, nightmares
Slovenian: 2, nočne more
English: In animal studies, brimonidine crossed the placenta and entered into the foetal circulation to a limited extent (see section 5.3).
Slovenian: V študijah na živalih je brimonidin v omejenih količinah prehajal skozi placento v krvni obtok ploda (glejte poglavje 5.3).
English: Although both brinzolamide and brimonidine lower IOP by suppressing aqueous humour formation, their mechanisms of action are different.
Slovenian: Čeprav tako brinzolamid kot brimonidin znižujeta očesni tlak z zmanjševanjem izločanja prekatne vodke, pa sta njuna mehanizma delovanja različna.
English: In rabbits oral, maternally toxic doses of brinzolamide of up to 6 mg/kg/day (261 times the recommended daily clinical dose of 23 µg/kg/day) revealed no effect on foetal development.
Slovenian: Pri kuncih peroralni in za samice toksični odmerki brinzolamida do 6 mg/kg/dan (261-kratnik priporočenega kliničnega dnevnega odmerka 23 µg/kg/dan) niso pokazali nobenih učinkov na razvoj ploda.
English: Other medicines and SIMBRINZA
Slovenian: Druga zdravila in zdravilo SIMBRINZA
English: The primary metabolite is N-desethylbrinzolamide, followed by the N-desmethoxypropyl and O-desmethyl metabolites, as well as an N-propionic acid analogue formed by oxidation of the N-propyl side chain of O-desmethyl brinzolamide.
Slovenian: Njegov glavni presnovek je N-desetilbrinzolamid, sledijo pa mu Ndesmetoksipropil in O-desmetilni presnovki, poleg tega pa tudi analog N-propionske kisline, ki nastane z oksidacijo N-propilne stranske verige O-desmetilbrinzolamida.
English: Retention in ocular tissues is prolonged due to binding to carbonic anhydrase.
Slovenian: Njegovo zadrževanje v očesnih tkivih je podaljšano zaradi vezave na karboanhidrazo.
English: The following adverse reactions have been reported during clinical studies with SIMBRINZA twicedaily dosing and during clinical studies and post-marketing surveillance with the individual components brinzolamide and brimonidine.
Slovenian: O naslednjih neželenih učinkih so poročali v kliničnih študijah z zdravilom SIMBRINZA v odmerkih dvakrat na dan ter v kliničnih študijah in spremljanju v obdobju trženja posameznih učinkovin, brinzolamida in brimonidina.
English: Some patients who dosed with SIMBRINZA experienced decreases in blood pressure similar to those observed with the use of brimonidine as monotherapy.
Slovenian: Nekateri bolniki, ki so prejeli odmerke zdravila SIMBRINZA, so imeli podobno znižanje krvnega tlaka, kot so ga opažali pri bolnikih, zdravljenih z brimonidinom v obliki monoterapije.
English: • Trouble breathing
Slovenian: • težko dihanje,
English: Uncommon: cardio-respiratory distress
Slovenian: Občasni: srčno-dihalna stiska
English: 2, blepharitis
Slovenian: 2, blefaritis
English: Brinzolamide pharmacokinetics are inherently non-linear due to saturable binding to carbonic anhydrase in whole blood and various tissues.
Slovenian: Farmakokinetika brinzolamida je nelinearna zaradi nasičenosti vezave na karboanhidrazo v polni krvi in različnih tkivih.
English: clomipramine, mianserin, venlafaxine and duloxetine - anaesthetics - sedatives, opiates, or barbiturates
Slovenian: nortriptilinom, klomipraminom, mianserinom, venlafaksinom in duloksetinom, - anestetike, - sedative, opiate ali barbiturate.
English: Not known: rhinitis
Slovenian: Neznana: rinitis
English: Patients with severe renal impairment (see section 4.4).
Slovenian: Bolniki s hudo ledvično okvaro (glejte poglavje 4.4).
English: Not known: arthralgia
Slovenian: Neznana: artralgija
English: Since the brinzolamide component of SIMBRINZA and its metabolite are excreted predominantly by the kidney, SIMBRINZA is contraindicated in such patients (see section 4.3).
Slovenian: Ker se brinzolamid iz zdravila SIMBRINZA in njegov presnovek izločata predvsem skozi ledvice, je zdravilo SIMBRINZA kontraindicirano pri teh bolnikih (glejte poglavje 4.3).
English: SIMBRINZA may also cause dizziness, drowsiness or tiredness in some patients.
Slovenian: Zdravilo SIMBRINZA lahko pri nekaterih bolnikih povzroči tudi omotico, dremavost ali utrujenost.
English: SIMBRINZA has a moderate influence on the ability to drive and use machines.
Slovenian: Zdravilo SIMBRINZA ima zmeren vpliv na sposobnost vožnje in upravljanja strojev.
English: What SIMBRINZA is and what it is used for What you need to know before you use SIMBRINZA How to use SIMBRINZA
Slovenian: Kaj je zdravilo SIMBRINZA in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo SIMBRINZA Kako uporabljati zdravilo SIMBRINZA Možni neželeni učinki
English: SIMBRINZA is therefore contraindicated in children below 2 years of age (see section 4.3).
Slovenian: Zdravilo SIMBRINZA je torej kontraindicirano pri otrocih, mlajših od 2 let (glejte poglavje 4.3).
English: Brinzolamide belongs to a group of medicines called carbonic anhydrase inhibitors and brimonidine tartrate belongs to a group of medicines called alpha-2 adrenergic receptor agonists.
Slovenian: Brinzolamid sodi v skupino zdravil, ki jim pravimo zaviralci karboanhidraze, brimonidinijev tartrat pa sodi v skupino zdravil, ki jim pravimo agonisti adrenergičnih receptorjev alfa-2.
English: SIMBRINZA has not been studied in patients with severe renal impairment (CrCl <30 mL/min) or in patients with hyperchloraemic acidosis.
Slovenian: Študij z zdravilom SIMBRINZA še niso izvedli pri bolnikih s hudo ledvično okvaro (očistek kreatinina < 30 ml/min) ali pri tistih s hiperkloremično acidozo.
English: What SIMBRINZA looks like and contents of the pack SIMBRINZA eye drops, suspension, is a liquid (white-to-off-white suspension) supplied in a pack containing one or three 5 ml plastic bottles with screw cap.
Slovenian: Izgled zdravila SIMBRINZA in vsebina pakiranja Zdravilo SIMBRINZA kapljice za oko, suspenzija, je tekočina (bela do belkasta suspenzija), ki je na voljo v pakiranju z enim ali tremi 5 ml kapalnimi vsebniki z navojno zaporko.
English: photophobia
Slovenian: fotofobija